A consortium of high-profile property and data figures has acquired a 41% stake in the land acquisition technology platform.
"This is an exciting strategic milestone for the business that demonstrates proof of concept, where we are leveraging sophisticated technological solutions to unlock a deeply opaque land market. Our new investors recognise that as the AI landscape evolves, there is early mover advantage to be had by backing emerging companies applying it to a part of the real estate market that has always suffered from a lack of innovation."
The funding round was led by Lightspeed Venture Partners and MMC Ventures to accelerate expansion into financial institutions.
"Compliance should be a growth enabler, not a bottleneck. Our vision is an agentic onboarding solution that fully automates KYB checks. We designed Condukt as an always-on nervous system that lives and breathes real-time data. By combining this proprietary data infrastructure with AI agents, we eliminate repetitive checks and ensure compliance keeps pace with any business change."
BGF backs mobile identity specialist TMT ID in its first institutional funding round to support international growth.
"We are delighted to announce BGF’s investment in TMT ID. At a time when fraud and digital threats are escalating worldwide, the ability to verify users, detect risk, and protect customers has never been more critical. TMT ID’s mobile identity and number intelligence solutions deliver real-time insights that allow enterprises to build trust, prevent fraud and optimise decision-making."
Siguler Guff has provided £11.4m in private equity backing to help launch the AI-focused consultancy.
"Advice from traditional consultancies is never impartial. You don’t know if the guidance you’re being given is right for your business, or theirs. And they lack the skills and expertise to really understand the AI revolution – you’re effectively paying for their transformation while trying to navigate your own. Valliance will always be independent. Our team of experts has a single aim: to help businesses reduce time to AI value. We’re not here to sell licenses – we’re here to deliver solutions that work for business, and with the existing IT estate."
BGF and Tencent join existing shareholders to support the biotechnology company in advancing its drug development programmes.
"We are delighted to have significantly added to our Series A financing, which we see as a strong validation of both our technology and our progress to date. I would like to thank Tencent and BGF for their belief in our potential, as well as all our existing investors for their continued support."
